Clinical trial Recruiting at 1 site Observational Ages 18 and up

Identifying biomarkers in kidney disease before and after transplantation

Official title: Diagnostic and PROgnostic BIOmarkers Before and After Kidney Transplantation

Run by Assistance Publique - Hôpitaux de Paris · NCT06810258 · Data updated 2026-11-12

This study is trying to find specific markers in urine, blood, and tissue that can help doctors better diagnose and predict kidney disease before and after a transplant.

More Kidney Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Créteil)
StatusRecruiting
StartedOctober 8, 2024
Main results expectedOctober 8, 2034
Study endsOctober 8, 2035
Registry record updatedFebruary 5, 2025
Trial IDNCT06810258 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years old who are hospitalized for a renal biopsy or kidney transplantation and can provide informed consent.

Probably not a fit

Patients who are pregnant, breastfeeding, under legal protection, or unable to give consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on identifying urinary, blood, and tissue biomarkers associated with kidney diseases, particularly in the context of kidney transplantation. By analyzing samples collected during native kidney biopsies and renal graft biopsies, the study aims to establish biomarkers that can aid in the diagnosis and prognosis of kidney conditions. The goal is to improve long-term kidney graft survival by enabling earlier and more accurate diagnosis compared to traditional biopsy methods, which are invasive and limited in scope.

Why it matters

Potential benefit: If successful, this study could lead to improved long-term survival rates for kidney transplants by allowing for earlier and more precise interventions.

How similar studies have gone: Other studies have shown promise in using biomarkers for kidney disease diagnosis, but this specific approach remains novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient hospitalised for renal biopsy of a native kidney or for renal transplantation
* Age \>18 years
* Informed and consented
* Covered by a social security scheme

Exclusion criteria:

* Patients under guardianship, conservatorship or legal protection
* Pregnant or breastfeeding
* Patient deprived of liberty
* Patients of legal age who are unable to give consent

Where it's running

  • Hôpital Henri Mondor
    Créteil, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.